CA
RBOT

CoreCap Advisors’s Vicarious Surgical RBOT Stock Holding History

CoreCap Advisors’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$315 Buy
+5
New +$465 ﹤0.01% 2227
2022
Q3 		– Sell
-5
Closed – – 1719
2022
Q2 		$0 Buy
+5
New +$611 ﹤0.01% 2243

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CoreCap Advisors's RBOT Position: Q4 2022 in Review

CoreCap Advisors opened a new position in Vicarious Surgical (RBOT) in Q4 2022: 5 shares worth $315. The stake represents ﹤0.01% of the portfolio and ranks #2227 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in RBOT as recently as Q2 2022.

CoreCap Advisors first reported a position in RBOT in Q2 2022 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold RBOT as of Q4 2022.

  • CoreCap Advisors held 5 shares of Vicarious Surgical worth $315 as of Q4 2022.
  • Vicarious Surgical was a new CoreCap Advisors position in Q4 2022.
  • Vicarious Surgical made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #2227 holding.
  • CoreCap Advisors first reported a position in Vicarious Surgical in Q2 2022 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.